Biotest AG (BIO3.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.07B |
| Enterprise Value | 1.56B |
| P/E Ratio | 48.06 |
| PEG Ratio | -0.42 |
| Price/Sales Ratio | 2.18 |
| Price/Book Ratio | 2.4 |
| Enterprise/Revenue | 2.85 |
| Enterprise/EBITDA | 17.22 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 726.2M |
| Revenue/Share | 18.35 |
| Gross Profit | 223.8M |
| EBITDA | 120.4M |
| Net Income | 26.4M |
| Diluted EPS | 0.67 |
Balance Sheet
| Total Cash | 59.8M |
| Total Cash/Share | 3.02 |
| Total Debt | 668.7M |
| Total Debt/Equity | 1.13 |
| Current Ratio | 5.06 |
| Book Value Per Share | 13.41 |
Price History
| 52-Week Change | 8.05 |
| 52-Week High | 32.8 |
| 52-Week Low | 24.6 |
| Moving Average 50 Days | 29.96 |
| Moving Average 200 Days | 28.23 |
Statistics
| Average Volume | 6,020 |
| Shares Outstanding | 49.19M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.06 |
| Last Split Factor | 3:1 |
| Last Split Date | July 15, 2015 |
AD
